- BIVI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
BioVie (BIVI) S-1/AIPO registration (amended)
Filed: 10 Mar 17, 12:00am
Weinberg & Baer LLC
115 Sudbrook Lane, Baltimore, MD 21208
Phone (410) 702-5660
Mr. Jonathan Adams, Chief Executive Officer
BioVie Inc. (F/K/A NanoAntibiotics, Inc.)
100 Cummings Center, Suite 247-C
Beverly, Massachusetts 01915
Dear Mr. Adams:
CONSENT OF INDEPENDENT AUDITOR
We have issued our report dated September 27, 2016, with respect to the financial statements of BioVie Inc. (F/K/A NanoAntibiotics, Inc.) contained in the Registration Statement and Prospectus of BioVie Inc. on Form S-1. We hereby consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the heading “Experts.”
Respectfully submitted,
Weinberg & Baer LLC
Baltimore, Maryland
March 9, 2017
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.